05/08/2024
7:00 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
5:19 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:51 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
7:46 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:48 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
7:49 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form ARS | |
04/09/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/08/2024
5:03 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
4:40 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:35 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:42 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
8:00 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
4:03 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:55 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:27 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/21/2024
7:31 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:15 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:29 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:16 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:18 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
01/19/2024
3:05 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
01/12/2024
3:01 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
11/22/2023
6:55 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:40 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:49 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:34 PM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:20 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Wu Charles C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:27 PM | GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:06 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 3/A | |
11/13/2023
4:13 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/13/2023
6:01 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:06 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
4:18 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 424B3 | |
11/01/2023
3:58 PM | GNI Group Ltd. (Filed by)
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
| Form SC 13D/A | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Wu Charles C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:15 AM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | Eastling Thomas Wilson (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:56 PM | GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2023
6:28 PM | GNI Group Ltd. (Filed by)
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
| Form SC 13D/A | |
10/30/2023
4:17 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2023
11:15 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form EFFECT | |
10/27/2023
6:56 PM | CATALYST BIOSCIENCES, INC. (Issuer)
Gyre Therapeutics (Issuer)
GNI Hong Kong Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
7:01 PM | CATALYST BIOSCIENCES, INC. (Issuer)
Gyre Therapeutics (Issuer)
GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/27/2023
4:27 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
4:10 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 424B3 | |
10/26/2023
4:22 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2023
3:08 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3/A | |
10/13/2023
3:25 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3/A | |
08/14/2023
5:01 AM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:40 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/20/2023
7:57 AM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEFM14A | |
06/26/2023
3:06 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form PRER14A | |
